| Mary Elizabeth Avery, MS, CCC-SLP | |
|
6317 Highway 329, Crestwood, KY 40014-9040 | |
| (502) 384-0910 | |
| Not Available |
| Full Name | Mary Elizabeth Avery |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 6317 Highway 329, Crestwood, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386952166 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 3806 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mary Elizabeth Avery, MS, CCC-SLP 4515 Timothy Way, Crestwood, KY 40014-9161 Ph: (502) 797-9681 | Mary Elizabeth Avery, MS, CCC-SLP 6317 Highway 329, Crestwood, KY 40014-9040 Ph: (502) 384-0910 |
News Archive
Genta Incorporated announced that the Company has received notification from the U.S. Food and Drug Administration (FDA) that Genta may resume clinical trials with tesetaxel, a leading oral taxane in Genta's oncology product portfolio.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced the initiation of a Phase 2 clinical trial evaluating the preliminary efficacy and safety of INNO-206 in patients with advanced pancreatic ductual adenocarcinomas (PDA) who have progressed after receiving two prior therapies.
"As we grow more interconnected, a range of complex risks, including climate change, environmental degradation, population growth, conflict, and food and fuel price volatility, are exacerbating the challenges faced by vulnerable communities," Ertharin Cousin, executive director of the U.N. World Food Programme (WFP); José Graziano da Silva, director general of the U.N. Food and Agriculture Organization (FAO); and Kanayo Nwanze, president of the International Fund for Agricultural Development (IFAD), write in the Huffington Post's "World Economic Forum" blog.
ChemoCentryx, Inc., today announced that it reported positive preclinical and Phase I study results at the European Association for the Study of Diabetes (EASD). CCX140, a novel, orally bioavailable small molecule antagonist of the chemokine receptor CCR2, improved metabolic function while significantly reducing inflammatory macrophages found in adipose tissue in an animal model, and was well tolerated in Phase I clinical trials.
› Verified 6 days ago
Mrs. Marci Jo Walker, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5413 Pearce Way, Crestwood, KY 40014 Phone: 502-807-7995 Fax: 502-241-5922 | |
Mary E Olson, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6317 Highway 329, Crestwood, KY 40014 Phone: 502-384-0910 | |
Miss Lindsay Michelle Hartmann, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6317 Highway 329, Crestwood, KY 40014 Phone: 502-384-0910 | |
Mrs. Kelsey Ann Schuhmann, M.S. CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 6317 Highway 329, Crestwood, KY 40014 Phone: 502-384-0910 | |
Briana Noelle Tingle, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6317 Highway 329, Crestwood, KY 40014 Phone: 502-384-0910 | |
Emily Marie Rhodes, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6317 Highway 329, Crestwood, KY 40014 Phone: 502-384-0910 | |
Mrs. Erin Renee Berg, M.S.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6317 Highway 329, Crestwood, KY 40014 Phone: 502-384-0910 |